Apogee Therapeutics
APGE
APGE
172 hedge funds and large institutions have $2.37B invested in Apogee Therapeutics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 62 increasing their positions, 56 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $2.51B → $2.37B (-$144M)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
22% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 32
Holders
172
Holding in Top 10
4
Calls
$12.8M
Puts
$5.26M
Top Buyers
| 1 | +$36.5M | |
| 2 | +$27.5M | |
| 3 | +$26.8M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$22.4M |
| 5 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$19.4M |
Top Sellers
| 1 | -$53.4M | |
| 2 | -$41.9M | |
| 3 | -$32.3M | |
| 4 |
SL
Siren LLC
Greenwich,
Connecticut
|
-$25.8M |
| 5 |
Jennison Associates
New York
|
-$11.7M |
